MONTRONI, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 2.755
EU - Europa 1.649
AS - Asia 1.307
SA - Sud America 219
AF - Africa 37
OC - Oceania 8
Totale 5.975
Nazione #
US - Stati Uniti d'America 2.727
SG - Singapore 513
SE - Svezia 370
UA - Ucraina 289
VN - Vietnam 263
RU - Federazione Russa 233
CN - Cina 205
BR - Brasile 167
DE - Germania 166
IE - Irlanda 148
DK - Danimarca 101
HK - Hong Kong 96
FR - Francia 95
GB - Regno Unito 73
FI - Finlandia 72
KR - Corea 66
TR - Turchia 66
IT - Italia 59
IN - India 21
AR - Argentina 16
BD - Bangladesh 15
BE - Belgio 15
ZA - Sudafrica 14
CA - Canada 13
IQ - Iraq 11
CO - Colombia 9
MA - Marocco 8
MX - Messico 7
EC - Ecuador 6
VE - Venezuela 6
AT - Austria 5
CI - Costa d'Avorio 5
JO - Giordania 5
MY - Malesia 5
NL - Olanda 5
PL - Polonia 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
KE - Kenya 4
NZ - Nuova Zelanda 4
PE - Perù 4
PY - Paraguay 4
UZ - Uzbekistan 4
CL - Cile 3
EG - Egitto 3
GE - Georgia 3
JP - Giappone 3
KZ - Kazakistan 3
LB - Libano 3
PH - Filippine 3
RO - Romania 3
UY - Uruguay 3
AL - Albania 2
AZ - Azerbaigian 2
ES - Italia 2
HN - Honduras 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
PK - Pakistan 2
SA - Arabia Saudita 2
TH - Thailandia 2
TW - Taiwan 2
BB - Barbados 1
BH - Bahrain 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
ID - Indonesia 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
ME - Montenegro 1
MT - Malta 1
RS - Serbia 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 5.975
Città #
Singapore 352
Chandler 347
Jacksonville 286
Ashburn 243
Boardman 158
Dublin 147
Wilmington 142
San Jose 136
Fairfield 120
Hong Kong 93
Dallas 88
Ho Chi Minh City 75
Ann Arbor 70
Seattle 70
Houston 67
San Mateo 66
Woodbridge 64
Beijing 60
Hanoi 58
Lawrence 58
Princeton 58
Des Moines 52
New York 51
Lauterbourg 50
Hefei 49
The Dalles 49
Los Angeles 44
Buffalo 31
Moscow 30
San Diego 25
Cambridge 21
Brussels 15
Helsinki 15
Da Nang 13
Orem 13
Chicago 11
Haiphong 11
Phoenix 10
São Paulo 10
Auburn Hills 9
Johannesburg 9
Seoul 9
Chennai 8
Council Bluffs 8
Ankara 7
Norwalk 7
Santa Clara 7
Washington 7
Rio de Janeiro 6
Stockholm 6
Thái Bình 6
Abidjan 5
Amman 5
Denver 5
Montreal 5
San Francisco 5
Shanghai 5
Warsaw 5
Bogotá 4
Bến Tre 4
Cape Town 4
Hanover 4
Hải Dương 4
London 4
Milan 4
Nairobi 4
Nuremberg 4
Rome 4
Tashkent 4
Baghdad 3
Biên Hòa 3
Boston 3
Brasília 3
Charlotte 3
Dhaka 3
Guangzhou 3
Karbala 3
Kuala Lumpur 3
Lima 3
Marche 3
Montevideo 3
Munich 3
Ninh Bình 3
Porto Alegre 3
Pune 3
Quanzhou 3
São João del Rei 3
Tbilisi 3
Tokyo 3
Torre Annunziata 3
Wuhan 3
Almaty 2
Anápolis 2
Asunción 2
Auckland 2
Baku 2
Barranquilla 2
Bologna 2
Brooklyn 2
Cachoeiro de Itapemirim 2
Totale 3.510
Nome #
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina (Durability and tolerability of long-term nevirapine-based HAART). 175
Abnormalities of erythropoiesis during HIV-1 disease: a longitudinal analysis. 174
Anticardiolipin antibodies expression in psoriasis 165
Higly active antiretroviral therapy induces specific changes in effector and central memory T cell sub-populations 150
Diagnosis of Immediate-Type ß-Lactam Allergy In Vitro by Flow-Cytometric Basophil Activation Test and Sulfi doleukotriene Production: a Multicenter Study. 138
Diagnosi sierologica nelle malattie autoimmuni non organo-specifiche. 138
Comparsa di polmonite in soggetto con storia recente di inappetenza, disfagia, calo ponderale, ed eritema diffuso. 133
Effects of cryopreservation on lymphocyte immunophenotype and function 131
Abnormal intracellular kinetics of cell –cycle-dependent proteins in lymphocytes from patients infected with human immunodeficiency virus: a novel biological link between immune activation, accelerated T- cell turnover and high levels of apoptosis 130
Exogenous IL-2 administration corrects the cell cycle perturbation of lymphocytes from HIV-infected individuals 126
High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome. 125
Triple nucleoside treatment with abacavir plus the lamivudine/zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naïve adults; results of a 48-week open-label, equivalence trial (CAN 3014) 125
Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy. 125
Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice? 124
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART. 122
Il ruolo del Medico di Medicina Generale nella diagnosi precoce della malattia da HIV. 117
Interruption of antiretroviral therapy is associated with increased plasma cystatin C. 116
Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naïve for Antiretrovirals 112
Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. 111
Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen. 110
Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy. 109
Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina. 106
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. 105
Specific changes in the post-translational regulation of nucleolin in lymphocytes from patients infected with human immunodeficiency virus 105
I vaccini, da Jenner ai vaccini a DNA 105
Addition of erythropoietin to granulocyte colony-stimulating factor after priming chemotherapy enhances hemopoietic progenitor mobilization. 102
Major clinical outcomes in antiretroviral therapy (ART)-naïve participants and in those not receiving ART at baseline in the SMART study. 101
Unscheduled cyclin B expression and p34 cdc2 activation in T-lymphocytes from HIV patients 100
Genotypic Resistance Tests for the Management of Structured Therapeutic Interruptions after Multiple Drug Failure: Prosecution 100
HIV-induced abnormalities in myelopoiesis and their recovery following antiretroviral therapy 98
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. 96
Sexual behaviour of heterosexual individuals with HIV infection naïve for antiretroviral therapy in Italy . 96
Impact of Higly Active Antiretroviral Therapy on the Presenting Features and Outcome of Patients with Acquired Immunodeficiency Syndrome-Related Kaposi Sarcoma 93
Lo studio fenotipico delle cellule mononucleate, linee guida all'impiego clinico, alla lettura ed all'interpretazione nelle diverse condizioni morbose. 93
Lo studio fenotipico di linfociti e altre cellule mononucleate. 93
Cervical dysplasia in HIV-seropositive women: role of human papillomavirus infection and immune status 93
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction. 92
Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis. 91
Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures. 91
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. 91
Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients. 90
Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients. 90
Impaired in-vitro growth of megakaryocytic colonies derived from CD34 cells of HIV-1-infected patients with active viral replicatio 90
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. 89
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. 88
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis. 86
Loss of CD127 (Interleukin-7 receptor) expression defines an expansion of “effector memory” CD8+Tcells in HIV-infected patients 86
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina. 81
Low prevalence of primary mutations associated with drug resistance in antiviral-naïve patients at therapy initiation 80
Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from tha italian cohort of antiretroviral-naïve patients study 79
Il paziente adulto con immunodeficienza. 78
Identikit della immunodeficienza da HIV. 73
Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up. 71
Il ruolo del Mmg nella diagnosi precoce della malattia da HIV. 68
Infezione da HIV-1. 67
La diagnosi immunologica delle Malattie Autoimmuni non Organo Specifiche 65
L’immunoricostituzione, un paesaggio dai mutevoli confini 64
Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the I.Co.N.A study 62
Totale 6.014
Categoria #
all - tutte 24.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.800


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202151 0 0 0 0 0 0 0 0 0 0 0 51
2021/2022441 13 96 2 61 8 21 8 43 26 56 23 84
2022/2023948 88 72 67 95 104 173 0 65 235 1 24 24
2023/2024404 85 11 17 73 70 62 8 8 0 4 12 54
2024/2025688 49 66 44 4 11 43 31 15 204 34 53 134
2025/20261.846 86 121 53 166 274 161 390 211 146 158 45 35
Totale 6.014